NCT02248948 - Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children | Biotech Hunter

Enrollment

231

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

DIETARY_SUPPLEMENT

Omega-3 Fatty Acids

Patients will receive a daily dose calculated based on the child weight (≤28 kg=4ml; 29-40 kg= 6ml and ≥41 kg=8ml) and will be provided once a day for 6 months.

DIETARY_SUPPLEMENT

Medium Chain Triglycerides

Patients will receive a daily dose calculated based on the child weight (≤28 kg=4ml; 29-40 kg= 6ml and ≥41 kg=8ml) and will be provided once a day for 6 months.

Trial Locations (1)

08017

Centro Médico Teknon, Barcelona